Education
About Us
Working with TipRanks
Follow Us
Progyny (PGNY)
NASDAQ:PGNY
PGNY Stock Chart & Stats
$23.24
$0.60(3.43%)
At close: 4:00 PM EST
$23.24
$0.60(3.43%)
Day’s Range― - ―
52-Week Range$17.98 - $28.75
Previous CloseN/A
Volume466.97K
Average Volume (3M)1.27M
Market Cap
$2.09B
Enterprise Value$1.89B
Total Cash (Recent Filing)$345.21M
Total Debt (Recent Filing)$24.73M
Price to Earnings (P/E)36.8
Beta0.55
Next Earnings
Mar 02, 2026EPS Estimate
0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.15
Shares Outstanding86,211,655
10 Day Avg. Volume1,337,052
30 Day Avg. Volume1,268,953
Financial Highlights & Ratios
PEG Ratio-3.15
Price to Book (P/B)3.74
Price to Sales (P/S)1.35
P/FCF Ratio9.08
Enterprise Value/Market Cap0.91
Enterprise Value/Revenue1.49
Enterprise Value/Gross Profit6.51
Enterprise Value/Ebitda19.85
Forecast
1Y Price Target
$29.89Price Target Upside28.61% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Capital ReturnThe announcement of a share repurchase authorization provides direct capital-return support that can underpin the stock during periods of uncertainty.
Client RetentionNear-perfect client renewal rates support business stability and signal durable recurring demand for the company's services.
Regulatory MandateFull implementation of the California IVF mandate broadens mandatory coverage and is expected to increase utilization of fertility services.
Bears Say
Guidance CredibilityMissing the target for lives added can erode investor confidence in management's execution and increase scrutiny of future targets.
New Business GenerationNew client wins came in below the firm's stated target for lives added, indicating softer sales momentum than expected.
Revenue Growth RiskA shortfall in newly covered lives may constrain near-term revenue expansion and delay the realization of scale benefits.
Progyny News
PGNY FAQ
What was Progyny’s price range in the past 12 months?
Progyny lowest stock price was $17.98 and its highest was $28.75 in the past 12 months.
What is Progyny’s market cap?
Progyny’s market cap is $2.09B.
When is Progyny’s upcoming earnings report date?
Progyny’s upcoming earnings report date is Mar 02, 2026 which is in 26 days.
How were Progyny’s earnings last quarter?
Progyny released its earnings results on Nov 06, 2025. The company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.127 by $0.023.
Is Progyny overvalued?
According to Wall Street analysts Progyny’s price is currently Undervalued.
Does Progyny pay dividends?
Progyny does not currently pay dividends.
What is Progyny’s EPS estimate?
Progyny’s EPS estimate is 0.15.
How many shares outstanding does Progyny have?
Progyny has 86,211,655 shares outstanding.
What happened to Progyny’s price movement after its last earnings report?
Progyny reported an EPS of $0.15 in its last earnings report, beating expectations of $0.127. Following the earnings report the stock price went up 24.209%.
Which hedge fund is a major shareholder of Progyny?
Currently, no hedge funds are holding shares in PGNY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Progyny Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$29.89 (28.61% Upside)
$29.89 (28.61% Upside)
Blogger Sentiment
Bullish
PGNY Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 389.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 12.9%
Last 30 Days ▲ 12.9%
Technicals
SMA
Positive
20 days / 200 days
Momentum
4.48%
12-Months-Change
Fundamentals
Return on Equity
11.37%
Trailing 12-Months
Asset Growth
20.49%
Trailing 12-Months
Company Description
Progyny
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
PGNY Company Deck
PGNY Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Progyny had a strong performance this quarter with revenue and profitability exceeding expectations, a successful selling season, and a high client renewal rate. However, challenges included slightly lower than expected new covered lives and impact from a large client loss. Overall, the positive aspects significantly outweigh the negative, indicating strong business momentum.View all PGNY earnings summariesPGNY Stock 12 Month Forecast
Average Price Target
$29.89
▲(28.61% Upside)
Technical Analysis
Ownership Overview
2.20% Insiders
31.83% Mutual Funds
2.22% Other Institutional Investors
37.35% Public Companies and
Individual Investors